Spain (ES)

Non-oscillating power spectra in loop quantum cosmology (2021) Elizaga de Navascués B, Mena Marugán GA, Prado S Journal article Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women (2021) Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Luccarini C, Wahlstrom C, Pooley KA, et al. Journal article The Role of ncRNAs in Solid Tumors Prognosis: From Laboratory to Clinical Utility (2021) Zhou J, Huang Z, Slaby O, Navarro A Journal article, Editorial Resource allocation explains lactic acid production in mixed-culture anaerobic fermentations (2021) Regueira A, Rombouts JL, Mauricio-Iglesias M, Lema JM, Kleerebezem R, Wahl SA Journal article The Asp1 pyrophosphatase from S. pombe hosts a [2Fe-2S]2+ cluster in vivo (2021) Rosenbach H, Walla E, Cutsail GE, Birrell JA, Pascual-Ortiz M, Debeer S, Fleig U, Span I Journal article Blue extreme disk-runaway stars with Gaia EDR3 (2021) Irrgang A, Dimpel M, Heber U, Raddi R Journal article Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor plus (HR plus ) metastatic breast cancer (MBC) who have previously received a taxane (2021) O'Shaughnessy J, Schwartzberg L, Piccart M, Rugo HS, Yardley DA, Cortes J, Untch M, et al. Conference contribution Treatment-related amenorrhea with T-DM1 plus pertuzumab (KP) is lower than with docetaxel/carboplatin/ trastuzumab/pertuzumab (TCHP) in the phase III neoadjuvant KRISTINE trial (2021) Hurvitz SA, Fresco R, Afenjar K, Stroyakovskiy D, Huang CS, Wildiers H, Jung KH, et al. Conference contribution High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE (2021) Harbeck N, Johnston S, Fasching P, Martin M, Toi M, Rastogi P, Song C, et al. Conference contribution Global Phase 3 Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy (2021) Rugo H, Chow LWC, Cortes J, Fasching P, He XB, Hsu P, Huang CS, et al. Conference contribution